Be a Smart Investor
Friday, March 31, 2017
J&J declares Actelion tender offer a success, sees closing in second quarter
Johnson & Johnson declared its $30 billion tender offer for Swiss biotechnology company Actelion successful on Friday.
from Mergers and Acquisitions http://ift.tt/2oovUb1
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment